Adult Radiation Clinical Trials
Brain/CNS
| Protocol | N0577 |
|---|---|
| Cancer Type: | Codeleted Anaplastic Glioma |
| Fast Facts |
Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG BN003 |
|---|---|
| Cancer Type: | MENINGIOMA |
| Fast Facts |
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Please check out the rare protocol list to locate other studies within this disease site.
Breast
| Protocol | CCTG MA.39 Adjuvant |
|---|---|
| Cancer Type: | LOW RISK NODE POSITIVE BREAST CANCER |
| Fast Facts |
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG BR002 |
|---|---|
| Cancer Type: | Newly Oligometastatic Breast Cancer |
| Fast Facts |
A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Cancer Control
| Protocol | NRG CC003 |
|---|---|
| Cancer Type: | SCLC |
| Fast Facts |
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Genitourinary
| Protocol | NRG GU002 |
|---|---|
| Cancer Type: | Prostate |
| Fast Facts |
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy with or Without Adjuvant Docetaxel
| Protocol | NRG GU005 |
|---|---|
| Cancer Type: | Prostate Cancer |
| Fast Facts |
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | SWOG S1806 |
|---|---|
| Cancer Type: | Bladder Cancer |
| Fast Facts |
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab In Localized Muscle Invasive Bladder Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Gynecologic
| Protocol | GOG 0263 |
|---|---|
| Cancer Type: | Stage I/IIA Cervical Cancer |
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
| Protocol | NRG GY006 |
|---|---|
| Cancer Type: | GYN-newly diagnosed, bulky stage |
| Fast Facts |
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
| Protocol | RTOG 0724 |
|---|---|
| Cancer Type: | Cervical Carcinoma |
Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy With or Without Adjuvant Chemotherapy in High-Risk Patients With Early-Stage Cervical Carcinoma Following Radical Hysterectomy
Please check out the rare protocol list to locate other studies within this disease site.
Head and Neck
| Protocol | EA3132 |
|---|---|
| Cancer Type: | Head and Neck |
| Fast Facts |
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
| Protocol | NRG HN005 |
|---|---|
| Cancer Type: | Oropharyngeal Cancer |
| Fast Facts |
A Randomized Phase II/III Trial of De-intensified Radiation Therapy for Patients with Early-Stage, p16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Lung
| Protocol | NRG LU002 |
|---|---|
| Cancer Type: | METASTATIC NON-SMALL CELL LUNG CANCER |
| Fast Facts |
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG CC003 |
|---|---|
| Cancer Type: | SCLC |
| Fast Facts |
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
